Werner Müller-Esterl

Werner Müller-Esterl's AcademicInfluence.com Rankings

Biology

#6288

World Rank

#8967

Historical Rank

Biochemistry

#788

World Rank

#894

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Werner Müller-Esterl Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Werner Müller-Esterl is a German biochemist who served as president of the Goethe University Frankfurt from 2009 to 2014. Career Born in Bonn, he studied chemistry and medicine at the University of Bonn and the Ludwig Maximilian University of Munich. He obtained his medical license in 1979 and his habilitation in clinical biochemistry in 1985. In 1987 he became professor of clinical biochemistry in Munich. In 1989 he became professor of pathobiochemistry at the University of Mainz. In 1999 he became professor of biochemistry at the Goethe University. He was director of the Institute for Biochemistry II and the Gustav Embden Center for Biological Chemistry from 2000. His research focuses on the molecular mechanisms that control the cardiovascular system.

(See a Problem?)

Werner Müller-Esterl's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. (2003) (933)
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences (2005) (910)
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. (2006) (421)
The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. (1996) (339)
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. (1986) (285)
Functional specialization of calreticulin domains (2001) (271)
The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family (1994) (259)
Cloning and Targeted Deletion of the Mouse Fetuin Gene* (1997) (250)
Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. (2011) (225)
Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation1 (2009) (223)
Host Cell Invasion by TRYPANOSOMA cRUZI Is Potentiated by Activation of Bradykinin B2 Receptors (2000) (219)
Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases (1998) (211)
NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase (2002) (187)
NOSIP, a novel modulator of endothelial nitric oxide synthase activity (2001) (183)
Streptococcal cysteine proteinase releases kinins: a virulence mechanism (1996) (176)
Isolation and Characterization of the Kininogen-binding Protein p33 from Endothelial Cells (1996) (176)
The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. (1998) (174)
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension (2000) (172)
Assembly of human contact phase proteins and release of bradykinin at the surface of curli‐expressing Escherichia coli (1996) (164)
Different protein turnover of interleukin-6-type cytokine signalling components. (1999) (146)
Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human Fibroblasts* (1996) (138)
Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5 (*) (1995) (131)
Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. (2007) (131)
Subcellular targeting and trafficking of nitric oxide synthases. (2006) (128)
Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells (2004) (123)
Probing for the bradykinin B2 receptor in rat kidney by anti-peptide and anti-ligand antibodies. (1995) (122)
Agonist-induced redistribution of bradykinin B2 receptor in caveolae. (1998) (120)
Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo (2004) (119)
NO‐synthase‐/NO‐independent regulation of human and murine platelet soluble guanylyl cyclase activity (2008) (115)
Identification of an endothelial cell binding site on kininogen domain D3. (1995) (113)
High Molecular Weight Kininogen Utilizes Heparan Sulfate Proteoglycans for Accumulation on Endothelial Cells* (2000) (113)
Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. (1985) (111)
Identification of a plasminogen‐binding motif in PAM, a bacterial surface protein (1995) (109)
Bradykinin-induced Internalization of the Human B2Receptor Requires Phosphorylation of Three Serine and Two Threonine Residues at Its Carboxyl Tail* (1999) (109)
Biochemical and Genetic Investigation of Round‐headed Spermatozoa in Infertile Men including two Brothers and their Father (2009) (107)
Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells. (1999) (106)
The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling. (1986) (105)
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation (2009) (104)
Phosphodiesterase 2A Forms a Complex with the Co-chaperone XAP2 and Regulates Nuclear Translocation of the Aryl Hydrocarbon Receptor* (2007) (103)
Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues (2002) (102)
Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal (2009) (98)
Identification of a Novel Maturation Mechanism and Restricted Substrate Specificity for the SspB Cysteine Protease ofStaphylococcus aureus * (2002) (97)
Kinin receptors in human vascular tissue: their role in atheromatous disease. (1997) (97)
Cyclic AMP Induces Transactivation of the Receptors for Epidermal Growth Factor and Nerve Growth Factor, Thereby Modulating Activation of MAP Kinase, Akt, and Neurite Outgrowth in PC12 Cells* (2002) (94)
Extracellular Domains of the Bradykinin B2 Receptor Involved in Ligand Binding and Agonist Sensing Defined by Anti-peptide Antibodies (*) (1996) (93)
Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. (2000) (92)
Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. (1995) (91)
Determination of Bradykinin B2 Receptor in Vivo Phosphorylation Sites and Their Role in Receptor Function* (2001) (91)
Heparan Sulfate Modulates Kinin Release by Trypanosoma cruzi through the Activity of Cruzipain* (2002) (90)
Assembly of contact-phase factors on the surface of the human neutrophil membrane. (1994) (89)
Molecular Co-operation between Protein PAM and Streptokinase for Plasmin Acquisition by Streptococcus pyogenes * (1998) (89)
Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN. (2006) (85)
Cooperative Activation of TLR2 and Bradykinin B2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection by Trypanosoma cruzi1 (2006) (83)
Palmitoylation of Endothelin Receptor A (1996) (82)
Cytoplasmic STAT proteins associate prior to activation. (2000) (80)
Local Bradykinin Formation Is Controlled by Glycosaminoglycans1 (2005) (80)
Bradykinin B2 Receptors of Dendritic Cells, Acting as Sensors of Kinins Proteolytically Released by Trypanosoma cruzi, Are Critical for the Development of Protective Type-1 Responses (2007) (80)
Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. (1992) (79)
Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor subtypes (B1/B2) (2003) (79)
Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. (1996) (78)
Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. (1992) (78)
Nitric Oxide Synthase (NOS)-Interacting Protein Interacts with Neuronal NOS and Regulates Its Distribution and Activity (2004) (76)
Genealogy of mammalian cysteine proteinase inhibitors (1985) (74)
Characterization of the H-kininogen-binding Site on Factor XI (2002) (73)
Identification by Mutational Analysis of Amino Acid Residues Essential in the Chaperone Function of Calreticulin* (2006) (71)
NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS (2005) (69)
Bradykinin Induces Translocation of the Protein Kinase C Isoforms α, ɛ, and ζ (1994) (66)
The Na+/H+ exchanger cytoplasmic tail: structure, function, and interactions with tescalcin. (2003) (66)
Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis. (1999) (66)
Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal (2009) (65)
Structural features of the human bradykinin B2 receptor probed by agonists, antagonists, and anti-idiotypic antibodies. (1993) (65)
Completion of the primary structure of human high-molecular-mass kininogen. The amino acid sequence of the entire heavy chain and evidence for its evolution by gene triplication. (1986) (64)
Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. (1997) (63)
The nucleotide and deduced amino acid structures of sheep and pig fetuin. Common structural features of the mammalian fetuin family. (1992) (63)
Coupling of endothelin receptors to the ERK/MAP kinase pathway. Roles of palmitoylation and G(alpha)q. (2001) (62)
Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation (2008) (62)
The Role of Bradykinin B1 and B2 Receptors for Secondary Brain Damage after Traumatic Brain Injury in Mice (2010) (62)
Kininogens, Kinins and Kinships (1989) (62)
Ontogeny of bradykinin B2 receptors in the rat kidney: implications for segmental nephron maturation. (1997) (61)
Overexpression and functional characterization of kinin receptors reveal subtype-specific phosphorylation. (1999) (61)
CK2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in the Endothelial Cell Plasma Membrane (2002) (61)
Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties. (1993) (60)
Human homolog of mouse tescalcin associates with Na+/H+ exchanger type‐1 (2001) (60)
ACE inhibitor potentiation of bradykinin‐induced venoconstriction (1997) (60)
Assembly of contact-phase factors on the surface of the human neutrophil membrane (1994) (59)
Mapping of the Discontinuous H-kininogen Binding Site of Plasma Prekallikrein (1999) (57)
Subtype-specific desensitization of human endothelin ETA and ETB receptors reflects differential receptor phosphorylation. (1997) (56)
Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells (1996) (56)
Distribution of bradykinin B2 receptors in sheep brain and spinal cord visualized by in vitro autoradiography (1997) (56)
Mutation of Tyrosine in the Conserved NPXXY Sequence Leads to Constitutive Phosphorylation and Internalization, but Not Signaling, of the Human B2 Bradykinin Receptor* (2004) (56)
Acrosin, the peculiar sperm-specific serine protease (1991) (54)
Differential Distribution of Bradykinin B2 Receptors in the Rat and Human Cardiovascular System (2001) (51)
Posttranslational processing of human alpha 2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells. (1994) (51)
Rat fetuin: distribution of protein and mRNA in embryonic and neonatal rat tissues (1998) (51)
Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions. (1988) (50)
Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis. (2007) (49)
Neutrophil-Derived Proteinase 3 Induces Kallikrein-Independent Release of a Novel Vasoactive Kinin12 (2009) (49)
Correlations in Palmitoylation and Multiple Phosphorylation of Rat Bradykinin B2 Receptor in Chinese Hamster Ovary Cells* (1999) (48)
Tissue kallikrein and kininogen in human sweat glands and psoriatic skin (1991) (47)
Structural and Functional Characterization of the Dimerization Region of Soluble Guanylyl Cyclase* (2004) (47)
Recent Progress on Kinins (1982) (46)
Immunolocalization of Bradykinin B2 Receptors on Skeletal Muscle Cells (1996) (46)
Limited proteolysis of human alpha2-HS glycoprotein/fetuin. Evidence that a chymotryptic activity can release the connecting peptide. (1996) (46)
Anti-idiotypic antibodies bearing the internal image of a bradykinin epitope. Production, characterization, and interaction with the kinin receptor. (1991) (45)
The Serum Protein α2-HS Glycoprotein/Fetuin Inhibits Apatite Formation in Vitro and in Mineralizing Calvaria Cells (1996) (45)
Cell Cycle-Regulated Inactivation of Endothelial NO Synthase through NOSIP-Dependent Targeting to the Cytoskeleton (2005) (45)
Visualisation of bradykinin B2 receptors on human brain neurons. (1996) (45)
Mapping of the Discontinuous Kininogen Binding Site of Prekallikrein (1996) (44)
Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model (2012) (44)
Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin. (2008) (43)
Angiotensin-Converting Enzyme (ACE) Dimerization Is the Initial Step in the ACE Inhibitor-Induced ACE Signaling Cascade in Endothelial Cells (2006) (43)
Contact-system activation in children with vasculitis (2002) (42)
[47] Sperm acrosin (1981) (42)
Cell surface‐associated chondroitin sulfate proteoglycans bind contact phase factor H‐kininogen (2001) (42)
Acrosin in the spermiohistogenesis of mammals. (1983) (42)
AGAP1, a Novel Binding Partner of Nitric Oxide-sensitive Guanylyl Cyclase* (2004) (41)
Na+ ions binding to the bradykinin B2 receptor suppress agonist-independent receptor activation. (1996) (39)
Endothelial kinin B1‐receptors are induced by myocardial ischaemia‐reperfusion in the rabbit (2001) (38)
Purification and properties of human low molecular weight kininogen. (1982) (37)
Boar acrosin is a two-chain molecule. Isolation and primary structure of the light chain; homology with the pro-part of other serine proteinases. (1984) (37)
Posttranslational Processing of Human α2-HS Glycoprotein (Human Fetuin) (1994) (37)
Purification and properties of boar acrosin. (1980) (35)
Proacrosin and the differentiation of the spermatozoa. (1983) (35)
Cloning and Functional Characterization of the Ornithokinin Receptor (1997) (35)
Amino acid sequence of the light chain of human high molecular mass kininogen. (1985) (34)
Receptor phosphorylation does not mediate cross talk between muscarinic M(3) and bradykinin B(2) receptors. (1999) (34)
Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies. (1990) (34)
Limited proteolysis of human low-molecular-mass kininogen by tissue kallikrein. Isolation and characterization of the heavy and the light chains. (1985) (34)
Activation of mitogen‐activated protein kinase by the bradykinin B2 receptor is independent of receptor phosphorylation and phosphorylation‐triggered internalization (1999) (34)
Distribution of the novel eNOS-interacting protein NOSIP in the liver, pancreas, and gastrointestinal tract of the rat. (2002) (33)
The F‐BAR protein NOSTRIN participates in FGF signal transduction and vascular development (2012) (33)
Novel functions of the kininogens. (1987) (32)
Human low-molecular-mass kininogen. Amino-acid sequence of the light chain; homology with other protein sequences. (1984) (31)
NOSIP and Its Interacting Protein, eNOS, in the Rat Trachea and Lung (2005) (31)
Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure. (2003) (31)
Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin. (1991) (30)
Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy. (2001) (30)
Expression of kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta (2006) (30)
High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. (1990) (30)
Reactive Oxygen Species Induce Tyrosine Phosphorylation of and Src Kinase Recruitment to NO-sensitive Guanylyl Cyclase* (2005) (29)
Interplay between parasite cysteine proteases and the host kinin system modulates microvascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex. (2006) (29)
Structure of the bradykinin B2 receptors' amino terminus. (1996) (29)
Characterization and localization of bradykinin B2 receptors in the guinea-pig using a radioiodinated HOE140 analogue. (1996) (29)
The N-terminal Amino Group of [Tyr8]Bradykinin Is Bound Adjacent to Analogous Amino Acids of the Human and Rat B2 Receptor* (1996) (28)
A new acrosin inhibitor from boar spermatozoa. (1982) (28)
Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression. (2003) (27)
[21] Human kininogens (1988) (27)
Cellular localization of human kininogens. (1992) (26)
Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor. (2003) (26)
Effects of Bradykinin and Endothelin-1 on the Calcium Homeostasis of Mammalian Cells (*) (1995) (26)
Arrangement of the disulphide bridges in human low-Mr kininogen. (1987) (25)
FCH/Cdc15 domain determines distinct subcellular localization of NOSTRIN (2006) (24)
Probing human β1- and β2-adrenoceptors with domain-specific fusion protein antibodies (1996) (24)
Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain. (1993) (24)
Tissue kallikrein and bradykinin B2 receptor in human uterus in luteal phase and in early and late gestation (2001) (24)
Cellular visualization of tissue prokallikrein in human neutrophils and myelocytes (1999) (24)
Regulation of Bradykinin Action at the Receptor Level (1990) (23)
Expression of Metallopeptidases and Kinin Receptors in Swine Oropharyngeal Tissues: Effects of Angiotensin I-Converting Enzyme Inhibition and Inflammation (2005) (23)
Monitoring of aprotinin plasma levels by an enzyme-linked immunosorbent assay (ELISA) (1984) (23)
Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes. (1992) (23)
Differential distribution of the vasopressin V receptor along the rat nephron during renal ontogeny and maturation. (2005) (23)
Tissue Kallikrein KLK1 Is Expressed de Novo in Endothelial Cells and Mediates Relaxation of Human Umbilical Veins (2001) (23)
Neutrophils engage the kallikrein‐kinin system to open up the endothelial barrier in acute inflammation (2018) (23)
Human cathepsins B, H and L: characterization by amino acid sequences and some kinetics of inhibition by the kininogens (1986) (21)
Localization of bradykinin B2 binding sites in rat kidney following chronic ACE inhibitor treatment. (1997) (20)
Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase (2005) (20)
Expression and cellular localization of kininogens in the human kidney. (1996) (19)
N-Terminal amino acid sequence of boar sperm acrosin. Homology with other serine proteinases. (1980) (19)
Bradykinin induces translocation of the protein kinase C isoforms alpha, epsilon, and zeta. (1994) (19)
Local Bradykinin Formation Is Controlled by Glycosaminoglycans (2005) (18)
Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: A possible role for tyrosine kinases (2000) (18)
Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum. (2009) (18)
Acrosin and the acrosome in human spermatogenesis (2004) (17)
Expression and Location of the Bradykinin B2 Receptor in Rat Testis1 (2002) (17)
Spinal upregulation of the nitric oxide synthase-interacting protein NOSIP in a rat model of inflammatory pain (2003) (17)
Cooperative Activation of TLR 2 and Bradykinin B 2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection by Trypanosoma cruzi 1 (2006) (17)
Human kininogens and their function in the kallikrein-kinin systems. (1984) (16)
Human kininogens. (1988) (16)
Synthesis of leupeptins and inhibition of proteinases. I. Inhibition of acrosin and trypsin. (1981) (16)
An NMR study of the interaction of 15N-labelled bradykinin with an antibody mimic of the bradykinin B2 receptor. (1997) (16)
Streptococcal inhibitor of complement-mediated lysis (SIC): an anti-inflammatory virulence determinant. (2010) (15)
Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2. (2002) (15)
Temporospatial Changes of Kinin B2 Receptors During the Estrous Cycle and Pregnancy in the Rat Uterus1 (2001) (15)
On the Teratogenesis of Round‐Headed Spermatozoa: Investigations with Antibodies Against Acrosin, an Intraacrosomally Located Acrosin‐Inhibitor, and the Outer Acrosomal Membrane (2009) (15)
Cellular distribution and fate of the bradykinin antagonist HOE 140 in the rat kidney. Colocalization with the bradykinin B2 receptor. (1996) (14)
Rapid Direct Determination of Low and High Molecular Weight Kininogen in Human Plasma by Particle Concentration Fluorescence Immunoassay (PCFIA) (1997) (14)
Bradykinin-B2 receptors in humans and rats: cDNA structures, gene structures, possible alternative splicing, and homology searching for subtypes. (1994) (14)
The Ubiquitin E3 Ligase NOSIP Modulates Protein Phosphatase 2A Activity in Craniofacial Development (2014) (14)
The mammalian cysteine proteinase inhibitors. Structural diversity and evolutionary origin (1986) (14)
Phosphodiesterase 2 A Forms a Complex with the Co-chaperone XAP 2 and Regulates Nuclear Translocation of the Aryl Hydrocarbon Receptor * (2007) (14)
Kinin receptor status in normal and inflammed gastric mucosa. (1997) (13)
Localization of the bradykinin B2 receptor in uterus, bladder and Madin-Darby canine kidney cells. (1997) (12)
Parallel Reduction of Plasma Levels of High and Low Molecular Weight Kininogen in Patients with Cirrhosis (1999) (12)
Interactions of boar acrosin with detergents. (1980) (12)
Endothelin-1 and endothelin receptor status in kidney transplants undergoing acute rejection. (1999) (11)
Discovery of a γ‐carboxyglutamic acid‐containing protein in human spermatozoa (1985) (11)
Two distinct Ca2+ influx pathways activated by the bradykinin B2 receptor. (1996) (11)
Oligomerisation of boar acrosin. (1980) (11)
Intra‐acrosomally located acrosin‐inhibitors: Evolution and developmental patterns in mammals (1984) (9)
New concepts in the treatment of chronic recurrent parotitis (2004) (9)
Limited Proteolysis of Human α2-HS Glycoprotein/Fetuin (1996) (9)
Vasopressin V 2 receptor expression along rat , mouse , and human renal epithelia with focus on (2007) (9)
Structural aspects of human kininogens. (1983) (9)
Peptidergic G protein-coupled receptors : from basic research to clinical applications (1999) (9)
Quantitation and differentiation of human kininogens by enzyme-linked immunosorbent assays (ELISA) (1984) (9)
Subtype-specific endothelin-A and endothelin-B receptor desensitization correlates with differential receptor phosphorylation. (1998) (9)
Localization of bradykinin B2 receptors in the endometrium and myometrium of rat uterus and the effects of estrogen and progesterone. (1999) (8)
Isolation of the endothelin B receptor from bovine lung. Structure, signal sequence, and binding site. (1995) (8)
Intra-acrosomal inhibition of boar acrosin by synthetic proteinase inhibitors. (1983) (8)
NOSTRINβ– A Shortened NOSTRIN Variant with A Role in Transcriptional Regulation (2009) (8)
Localization of bradykinin B2 receptors in sheep uterus. (1996) (8)
Probing human beta 1- and beta 2-adrenoceptors with domain-specific fusion protein antibodies. (1996) (8)
IMMUNOLOGICAL CHARACTERIZATION OF NATURAL AND SEMISYNTHETIC APROTININ VARIANTS (1989) (7)
Inhibition of B2 receptor internalization delays its dephosphorylation. (1997) (7)
Immunological Probes for the Bradykinin B2 Receptor. A Toolbox (1997) (7)
Subcellular targeting of multiligand-binding protein gC1qR. (1999) (7)
[Hyp3]‐bradykinin and [Hyp3]‐Lys‐bradykinin interact with B2‐bradykinin receptors and stimulate inositol phosphate production in cultured human fibroblasts (1990) (6)
Cloning and Functional Characterization of the Ornithokinin Receptor RECOGNITION OF THE MAJOR KININ RECEPTOR ANTAGONIST, HOE140, AS A FULL AGONIST* (1997) (6)
Fetuin--a new acute phase protein in the adult and in the fetus. (1992) (6)
International Committee Communications Subcommittee on Contact Activation Nomenclature of Kininogens (1988) (6)
The amino acid sequence of the light chain of human high-molecular-mass kininogen. (1985) (6)
Human plasma kininogens are identical with α‐cysteine proteinase inhibitors (5)
Kinin B2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats. (2003) (5)
Quantitative Determination of Different Proteins in Normal and Pathological Semen (1985) (5)
Rat bradykinin B2 receptor: immunochemical characterization and immunovizualization in epithelial and smooth muscle cells. (1996) (5)
On the structure of the amino-terminal domain ED1 of the B2 receptor. (1996) (5)
Changes in amino-terminal portion of human B2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin. (2003) (5)
Cloning and Functional Characterization of the Ornithokinin Receptor RECOGNITION OF THE MAJOR KININ RECEPTOR ANTAGONIST , HOE 140 , AS A FULL AGONIST (1997) (4)
On the evolution of mammalian kininogens. (1986) (4)
NMR investigations of recombinant 15N/13C/2H-labeled bradykinin bound to a Fab mimic of the B2 receptor. (1997) (4)
Probing human beta1- and beta2 -adrenoceptors with domain-specific fusion protein antibodies. (1997) (4)
Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues : effects of ACE inhibition and inflammation (2005) (4)
A curve-fitting approach to the determination of kinetic constants of proteinase inhibitors (1986) (4)
Plaque-lift testing of expression vector λgt11 with gold-labeled immunoglobulins (1988) (4)
OUTSIDE-IN SIGNALLING BY THE ANGIOTENSIN CONVERTING ENZYME IN ENDOTHELIAL CELLS: A NOVEL SIGNALLING PATHWAY (2004) (4)
On the structure of the amino-terminal domain ED1 of the B2 receptor. (1996) (4)
Intra-peritoneal aprotinin therapy for acute pancreatitis. Preliminary pharmacodynamic studies. (1988) (3)
Significance of Autocrine and Paracrine Signaling for Energy Metabolism in Contracting Skeletal and Cardiac Muscle Tissues. Symposium proceedings. Buhlerhohe, Germany, September 3-4, 1994. (1996) (3)
Sperm Acrosin: Liberation from the Acrosome and Activity of the Free Proteinase in the Presence of Nonoxinol‐9 * (2009) (3)
Molecular cloning of the cDNA coding for human C1 inhibitor. (1988) (3)
Effect of aprotinin on metabolic changes in blood following aortofemoral bypass operation. (1985) (3)
Inhibition of the Kallikrein-Kinin System in Vasogenic Brain Edema (1985) (3)
Limited proteolysis of HMW kininogen by plasma kallikrein in man--evidence for a processing mechanism different from the bovine system. (1986) (3)
Oxidative stress induces CHIP-mediated ubiquitination and roteasomal degradation of soluble guanylyl cyclase (2007) (2)
Anti‐Idiotypic Antibodies Against the Kinin Receptor (1992) (2)
Autoradiographic and immunological techniques to analyse kinin receptor distribution in rat and human tissues. (1998) (2)
Localization of Bradykinin B 2 Receptors in the Endometrium and Myometrium of Rat Uterus and the Effects of Estrogen and Progesterone* (1999) (2)
Bradykinin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
Discovery of a gamma-carboxyglutamic acid-containing protein in human spermatozoa. (1985) (1)
Kallikreins, Kinins and Allergy (1981) (1)
Tyrosine phosphorylation of NO-sensitive guanylyl cyclase (2005) (1)
Endothelial Cell Dysfunction—Can One Outsmart Oxidative Stress by Direct Interaction with the Pathological Oxidized or Heme-Free Soluble Guanyl-Cyclase? Targeting the Heme-Oxydized Nitric Oxide Receptor for Selective Vasodilatation of Diseased Blood Vessels. J Clin Invest 116: 2552–2561, 2006 (2007) (1)
189 Hepatic inflammation increases portal pressure through inhibition of eNOS activity — Potential mechanisms (2006) (1)
the Endothelial Cell Plasma Membrane CK 2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in (2002) (1)
STUDIES ON THE RENAL KALLIKREIN-KININ SYSTEM (1987) (1)
Kallikreins and Kininogenases (2002) (1)
Developmental activation and segment-specific co-expression of kininogen and bradykinin (BK) B2-receptors during rat nephrogenesis. • 2143 (1996) (1)
Search for autoantibodies to the human bradykinin B2 receptor. (1997) (0)
Introduction (1996) (0)
Treatment of Vasogenic Brain Edema by Inhibitors of the Kallikrein-Kinin System (1986) (0)
Interaction of NO-sensitive guanylyl cyclase with Src-like kinases (2005) (0)
Characterization of MRIP2 as a NO-sensitive guanylyl cyclase-associated protein (2005) (0)
Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain. (1992) (0)
RELATIONS BETWEEN APROTININ CONCENTRATIONS AND HEMODYNAMICS IN EXPERIMENTAL ACUTE PANCREATITIS (1987) (0)
Vasoactive Kinin Kallikrein-Independent Release of a Novel Neutrophil-Derived Proteinase 3 Induces (2009) (0)
Correction: Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. (2020) (0)
Cystatins and Cystatin-like Domains of Multifunctional Proteins: Solid-phase Microsequencing as a Tool to Study Structure-Function Relationships of Protein Inhibitors (1989) (0)
The E.K. Frey-E. Werle Foundation of the Henning L. Voigt Family (1992) (0)
Oxidative stress induces CHIP-mediated ubiquitination and roteasomal degradation of soluble guanylyl cyclase : oral presentation (2007) (0)
B-1 – ADHESION SPECIFICITY TO ENDOTHELIAL CELL RECEPTORS OF PLASMODIUM FALCIPARUM ISOLATES FROM RONDONIA (WESTERN AMAZON REGION, BRAZIL) (1999) (0)
Anti-idiotypic antibodies against the kinin receptor. (1992) (0)
Spotlight on cellular signaling. (2004) (0)
neutrophil membrane Assembly of contact-phase factors on the surface of the human (2011) (0)
O15. NOSIP is required for regulation of eNOS activity in proliferating endothelial cells (2006) (0)
NOSTRIN - a molecular clamp securing the eNOS-caveolin complex (2003) (0)
Discordant Spatial Expression of Proliferating Cell Nuclear Antigen (PCNA) and Bradykinin B2 Receptors (B2R) Implicates Kinins in Segmental Nephron Differentiation † 1832 (1998) (0)
Localization of the Bradykinin B2 Receptor in Rat (1999) (0)
Award ceremony of the E.K. Frey-E. Werle Foundation of the Henning L. Voigt family. (1997) (0)
Binding of Kininogen to the surface of Streptococcus pyogenes in plasma environment is followed by release of bradykinin. (1996) (0)
Angiotensin converting enzyme (ACE) inhibitors elicit the dimerization of ACE: an essential step for ACE‐dependent signaling in endothelial cells (2006) (0)
C 1 q Receptor , Is a Mitochondrial Protein The Multiligand-Binding Protein gC 1 qR , Putative (1998) (0)
Identification of proteins associated with soluble guanylyl cyclase (2003) (0)
Trypanosoma cruzi Model of Subcutaneous Infection by Induction of Type 1 Immunity in a Mouse Receptor Is Required for 2 Bradykinin B Cooperative Activation of TLR 2 and (2006) (0)
Correction: Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model (2012) (0)
Angiotensin converting enzyme (ACE) inhibitors induce an ACE-dependent signalling in endothelial cells via the initial dimerisation of ACE (2006) (0)
In memoriam Kanti D. Bhoola (1930–2019) (2020) (0)
Mechanismen der Katalyse (2018) (0)
C1q Receptor, Is a Mitochondrial Protein The Multiligand-Binding Protein gC1qR, Putative (2017) (0)
Meeting Report Spotlight on Cellular Signaling (2004) (0)
Bradykinin receptors in GtoPdb v.2021.3 (2021) (0)
Kininogens and Kinins (2002) (0)
Plaque-lift testing of expression vector lambda gt11 with gold-labeled immunoglobulins. (1988) (0)
The novel gene nostrin and a splice-variant are highly expressed in alcoholic hepatitis and may explain increased intra-hepatic resistance despite normal eNOS expression (2004) (0)
Oxidative Phosphorylierung – Elektronentransport und ATP-Synthese (2018) (0)
Amino acid sequence of the light chain of human low molecular mass kininogen. (1986) (0)
The Frey-Werle Foundation award ceremony, Friday, October 23, 1998, Noh Hall, Nara New Public Hall. (1999) (0)
GlycosaminoglycansLocal Bradykinin Formation Is Controlled by (2013) (0)
O93. Nitric oxide synthase interacting protein NOSIP is critical for angiogenesis and blood vessel stability during embryogenesis (2008) (0)

This paper list is powered by the following services:

Other Resources About Werner Müller-Esterl

en.wikipedia.org

What Schools Are Affiliated With Werner Müller-Esterl?

Werner Müller-Esterl is affiliated with the following schools: